Search results
Update on Aflibercept BPCIA Litigation | JD Supra
JD Supra· 7 days agoIn a sealed order that issued on June 11, the Court granted a permanent injunction in favor of Regeneron against Mylan/Biocon in the pending aflibercept BPCIA litigation.
Biotech Catapults On 'Unprecedented' Results For Gel-Based Drug
Investor's Business Daily· 6 days agoAfter three months, 79.6% of patients treated with UroGen Pharma's (URGN) drug had a complete...
My son's video game habit worried me but it fueled his interest in coding, robots, and AI. At age...
Business Insider via Yahoo News· 2 days agoThey had so much electronics in there. In 2021, when he was 16, John won the $50,000 Gordon E. Moore...
Lingering cholesterol can keep heart risk high. Marea Therapeutics has $190M to target it.
BioPharma Dive via Yahoo Finance· 2 days agoThe bar will be high. Novartis, which was the source of Marea’s lead prospect, brought a...
What's the MACE Risk With Moderate to Severe Eczema?
Medscape· 23 hours agoThe findings contrast with the expectation that increased systemic inflammation in moderate to severe AD would correspond with a higher incidence of...
Diana Taurasi on state of WNBA, arrival of Caitlin Clark and Team USA roster
USA Today· 3 days agoDiana Taurasi stopped by to chat about all-things basketball and her partnership with Sanofi and Regeneron to fight against eczema.
Splits Coming? 13 Stocks Still Cost A Ridiculous $1,000 Or More
Investor's Business Daily· 2 days ago...Health Care Fair Isaac 1,409.96 21.1% Information Technology TransDigm 1,318.91 30.4% Industrials...
My son's video game habit worried me but it fueled his interest in coding, robots, and AI. At age...
Business Insider· 2 days agoMaria Estrada worried her son was playing too many video games, but soon he was also flying drones,...
New JAK 1 Inhibitor Proves Promising in Phase 3 RA Trial
Medscape· 23 hours agoThe highly selective oral Janus kinase (JAK) inhibitor SHR0302 (ivarmacitinib) enables more patients...
Can Dupilumab Halt Atopic March in Pediatric AD?
Medscape· 23 hours agoDupilumab therapy was more effective than conventional treatments in reducing the risk of developing allergic rhinitis or asthma in children with atopic...